Patents by Inventor Albert Simone

Albert Simone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5800781
    Abstract: A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics.
    Type: Grant
    Filed: September 25, 1996
    Date of Patent: September 1, 1998
    Assignee: International Technidyne Corporation
    Inventors: Michael Gavin, Catherine M. Cimini, Ming Huang, Anthony Kuklo, Jr., James A. Mawhirt, Eduardo Marcelino, Albert Simone
  • Patent number: 5591403
    Abstract: A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: January 7, 1997
    Assignee: International Technidyne Corporation
    Inventors: Michael Gavin, Catherine M. Cimini, Ming Huang, Anthony Kuklo, Jr., James A. Mawhirt, Eduardo Marcelino, Albert Simone
  • Patent number: 5504011
    Abstract: A portable device for performing coagulation tests on a patient's blood. Blood is first drawn from a patient using a lancet. The blood is then supplied to a disposable cuvette placed within the testing device. The blood is drawn into multiple conduits within the cuvette. Each of the conduits contains a dried or lyophilized activation reagent that is rehydrated by the blood. The blood in each of the conduits is then reciprocally moved across a restricted region until a predetermined degree of coagulation occurs. Since the coagulation time is being monitored in multiple conduits, a representation coagulation time for a given sample can be determined. In at least one of the conduits a normalizing control agent is present. The normalizing control agent counteracts any effects of anticoagulants present in the blood sample, thereby allowing the blood sample to have generally normal coagulation characteristics.
    Type: Grant
    Filed: October 21, 1994
    Date of Patent: April 2, 1996
    Assignee: International Technidyne Corporation
    Inventors: Michael Gavin, Catherine M. Cimini, Ming Huang, Anthony Kuklo, Jr., James A. Mawhirt, Eduardo Marcelino, Albert Simone